Items where authors include "Yildiz, O."

Article

Bensimon, G., Leigh, P.N., Tree, T. et al. (50 more authors) (2025) Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial. The Lancet, 405 (10492). pp. 1837-1850. ISSN 0140-6736

Yildiz, O., Hunt, G.P. orcid.org/0000-0002-5217-2678, Schroth, J. et al. (9 more authors) (2025) Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis. Brain Communications, 7 (1). fcae402. ISSN 2632-1297

Yildiz, O., Schroth, J., Tree, T. et al. (4 more authors) (2023) Senescent-like blood lymphocytes and disease progression in amyotrophic lateral sclerosis. Neurology: Neuroimmunology & Neuroinflammation, 10 (1). ISSN 2332-7812

Thompson, A.G., Gray, E., Verber, N. et al. (20 more authors) (2022) Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Communications, 4 (1). fcac029. ISSN 2632-1297

Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2864

Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2856